Kimberly Ha/LinkedIn
Apr 3, 2026, 17:33
Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
Kimberly Ha, Founder and CEO at KKH Advisors, shared a post on LinkedIn:
”Epia Neuro is the latest medtech startup looking to tap the potential of brain-computer interface (BCI) technology, launching with a device that aims to turn brain signals into digital commands.
The San Francisco-based company is focusing its neural interface platform initially on stroke survivors.
The platform combines a minimally invasive, long-lifetime read/write brain-computer interface (pictured above) with assistive devices and AI-driven support, aiming to help stroke survivors translate neural signals into functional movement, according to an April 2 release.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care